ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Ellen Stoval Calls For More Funding for All Cancer Research

June 6, 1997

AACR to honor eight scientists with lecture awards.

February 13, 2004

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990